22 May 2018

London, 22 May 2018 - Mereo BioPharma Group plc (AIM: MPH), a clinical stage, UK-based, biopharmaceutical company focused on rare and specialty diseases, confirms that the Notice of the Annual General Meeting and a Form of Proxy will be posted to shareholders on 22 May 2018.

The Annual General Meeting is to be held on Thursday 21 June 2017 at 11.30am BST at the offices of Latham and Watkins (London) LLP, 99 Bishopsgate, London EC2M 3XF.

A copy of the Annual Report & Accounts for the year ended 31 December 2017 and the Notice of Annual General Meeting is available on the Company's website: www.mereobiopharma.com.

 

CLICK HERE TO VIEW THE NOTICE OF AGM